Infliximab and Pyoderma Gangrenosum in IBD: Clinical Images

J Clin Rheumatol. 2020 Dec;26(8):e328-e329. doi: 10.1097/RHU.0000000000001186.

Authors

David J Ozeri¹, Moriel Tagar Sar-El, Merav Lidar

Affiliation

¹ From the Department of Rheumatology, Sheba Medical Center, Ramat Gan, Israel.

PMID: 31688345
DOI: 10.1097/RHU.0000000000001186

No abstract available

MeSH terms

Antibodies, Monoclonal
Dermatologic Agents* / therapeutic use
Humans
Inflammatory Bowel Diseases*
Infliximab
Pyoderma Gangrenosum* / diagnosis
Pyoderma Gangrenosum* / drug therapy
Pyoderma Gangrenosum* / etiology

Substances

Antibodies, Monoclonal
Dermatologic Agents
Infliximab